Janssen-Cilag Farmacéutica Company Profile

05:02 EDT 21st March 2018 | BioPortfolio



Mendoza 1259
Buenos Aires


Phone: (011)4789-7270

News Articles [299 Associated News Articles listed on BioPortfolio]

CHMP Issues A Positive Opinion On Janssen-Cilag International NV???s Zytiga To Include Earlier Stage Prostate Cancer Patients

CHMP Recommends to Broaden Indication to Include the Treatment of Men with Newly Diagnosed High-Risk Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) BEERSE, Belgium--(BUSINES...

Saliva-based diagnostics offer possibility to detect HPV-induced throat cancer

This follows the extension of a QUT collaboration with Johnson & Johnson Innovation, Janssen Vaccines & Prevention, and Janssen Cilag Pty Ltd.

Janssen seeks EMA approval for Darzalex for newly diagnosed multiple myeloma

Janssen-Cilag International has submitted a Type II variation application to the European Medicines Agency (EMA), for its immunotherapy Darzalex (daratumumab).

Excelencia farmacéutica italiana en I+D durante el 33rd Congress of the European Association ...

     (Logo: Fidia Farmaceutici anunció hoy los resultados positivos de un ensayo en fase II en el que se evalúa la efica...

AZTherapies, Inc. nomeia Karen Reeves, MD, presidente e CMO (chief medical officer)

A AZTherapies, Inc. é uma empresa farmacêutica privada de estágio clínico avançado, sediada em Boston, Massachusetts, que está desenvolvendo tratamentos revolucionários para a doença Read ...

Janssen reports positive Phase ll and lll data of imbruvica

Janssen-Cilag International has reported positive results from a pooled analysis that includes Phase ll and lll studies of imbruvica (ibrutinib)...Read More... The post Janssen reports positive Phase ...

Nuevo Developer Portal Gateway API de Ambrosus para la cadena de suministro 2.0

Ambrosus - la solución líder del mundo de blockchain-IoT para asegurar la calidad en la industria alimentaria y farmacéutica - ha presentado su nuevo Developer Read more...

First IL-23 targeting biologic to rival psoriasis big-sellers in EU

Janssen-Cilag International, part of the US healthcare giant Johnson & Johnson, has announced that the…

Drugs and Medications [50 Associated Drugs and Medications listed on BioPortfolio]

Pasta de lassar andromaco [MarcasUSA LLC]

Drug Facts

Long last make up 02 (neo heliopan) [Janssen Cosmetics GmbH]

Drug Facts

Risperidone [WOCKHARDT USA LLC.]

These highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Sol...


These highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Sol...

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Comment from the Editor-in-Chief on the Letter to the Editor from Larry Janssen and Roy McKay representing the AIHA Respiratory Protection Committee.

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.

In recent years, the anti-CD38 monoclonal antibody daratumumab (Darzalex; Janssen-Cilag Pty Ltd) has been shown to be highly efficacious in relapsed and refractory multiple myeloma, with the final res...

Blau-Jabs Syndrome in a Tertiary Ophthalmologic Center.

In a prospective case series of patients with Blau-Jabs syndrome (BJS) conducted in the Ophthalmology Department/Federal University of Sao Paulo, seven patients with clinical and ophthalmologic manife...

Los receptores epidérmicos humanos en el cáncer gástrico: alteraciones moleculares y su papel como diana terapéutica.

Gastric cancer (GC) is the third leading cause of cancer death worldwide; both environmental and genetic factors are involved in the etiology of this neoplasia. The human epidermal receptor (HER) path...

Clinical Trials [21 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Efficacy and Safety of HX 575 vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients

This is a double-blind, randomized, multicenter, parallel-group, equivalence study involving about 462 clinically stable hemodialysis patients aged 18 years or above suffering from anemia ...

Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride

to evaluate the bioavailability of ambroxol hydrochloride soft pastilles (test formulation), manufactured by Bolder Arzneimittel GmbH & Co. KG to Boehringer Ingelheim compared to ambroxol ...

Trial Evaluating Folic Acid Supplementation by Concomitant Administration of Ethinyl Estradiol + Levonorgestrel

This trial evaluated folic acid supplementation after oral administration of the ethinyl estradiol + levonorgestrel + folic acid (0.02 mg + 0.10 mg + 0.4 mg) coated tablet (Level-Fol® Bio...

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

This is a randomized, double-blind, multicenter clinical phase III study involving about 105 cancer patients aged >18 years who are receiving palliative chemotherapy and who are suffering ...

Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate

This clinical trial evaluated the comparative bioavailability of two injectable suspension formulations of medroxyprogesterone acetate + estradiol cypionate, a test (Depomês®, 25 mg/mL m...

Companies [49 Associated Companies listed on BioPortfolio]

Janssen-Cilag Farmacéutica


Janssen-Cilag EMEA, EMHF, ESHA & ISG

Janssen-Cilag EMEA, a division of Janssen Pharmaceutica N.V., is a research-based pharmaceutical company that develops and markets innovative, high-quality pharmaceutical products and services aim...

Janssen-Cilag International NV

Janssen-Cilag AG



Since 1961 Janssen-Cilag has been a member of the Johnson & Johnson family of companies. Founded in 1886, Johnson & Johnson today is the world's most comprehensive manufacturer of healthcare products ...

More Information about "Janssen-Cilag Farmacéutica" on BioPortfolio

We have published hundreds of Janssen-Cilag Farmacéutica news stories on BioPortfolio along with dozens of Janssen-Cilag Farmacéutica Clinical Trials and PubMed Articles about Janssen-Cilag Farmacéutica for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Janssen-Cilag Farmacéutica Companies in our database. You can also find out about relevant Janssen-Cilag Farmacéutica Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record